The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways

Antioxidants and Redox Signaling

Volumn 5, Issue 2, 2003, Pages 163-169

  Huber, Joakim ^a   Bochkov, Valery N ^a   Binder, Bernd R ^a   Leitinger, Norbert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN E2; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SYNAPTOPHYSIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MONOCYTE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0037392219     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603764816523     Document Type: Article

References (27)

1. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, and Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85: 1260-1266, 1990.
2. ++/NFAT. Blood 99: 199-206, 2002.
3. Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, and Patrono C. In vivo formation of 8-epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 17: 3230-3235, 1997.
4. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, and Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation [see comments]. Circulation 99: 224-229, 1999.
5. Fogelman AM, Elahi F, Sykes K, Van LB, Territo MC, and Berliner JA. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res 29: 1243-1247, 1988.
6. Fukunaga M, Makita N, Roberts LJ, Morrow JD, Takahashi K, and Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 264: C1619-C1624, 1993.
7. Fukunaga M, Yura T, and Badr KF. Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol 26 (Suppl 3): S51-S52, 1995.
8. Gniwotta C, Morrow JD, Roberts LJ 2nd, and Kuhn H. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 17: 3236-3241, 1997.
9. Huber J, Boechzelt H, Karten B, Surboeck M, Bochkov VN, Binder BR, Sattler W, and Leitinger N. Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway. Arterioscler Thromb Vasc Biol 22: 581-586, 2002.
10. Kinsella BT, O'Mahony DJ, and Fitzgerald GA. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther 281: 957-964, 1997.
11. Leitinger N, Huber J, Rizza C, Mechtcheriakova D, Bochkov V, Koshelnick Y, Berliner JA, and Binder BR. The isoprostane 8-iso-PGF(2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation. FASEB J 15: 1254-1256, 2001.
12. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
13. Mohler ER, Franklin MT, and Adam LP. Intracellular signaling by 8-epi-prostaglandin F2 alpha is mediated by thromboxane A2/prostaglandin endoperoxide receptors in porcine carotid arteries. Biochem Biophys Res Commun 225: 915-923, 1996.
14. Moore KP, Darley UV, Morrow J, and Roberts LJ: Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res 77: 335-341, 1995.
15. Morrow JD and Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36: 1-21, 1997.
16. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, and Roberts LJ. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-1203, 1995.
17. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, and Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92: 471-478, 1993.
18. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, and Demer LL. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680-687, 1997.
19. Pratico D, Smyth EM, Violi F, and FitzGerald GA. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. J Biol Chem 271: 14916-14924, 1996.
20. Pratico D, Tangirala RK, Rader DJ, Rokach J, and Fitz-Gerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4: 1189-1192, 1998.
21. Reilly M, Delanty N, Lawson JA, and FitzGerald GA: Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 19-25, 1996.
22. Reilly MP, Pratico D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, and FitzGerald GA. Increased formation of distinct F2 isoprostanes in hypercholesterolemia [see comments]. Circulation 98: 2822-2828, 1998.
23. Shih PT, Brennan ML, Vora DK, Territo MC, Strahl D, Elices MJ, Lusis AJ, and Berliner JA. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 84: 345-351, 1999.
24. Shih PT, Elices MJ, Fang ZT, Ugarova TP, Strahl D, Territo MC, Frank JS, Kovach NL, Cabanas C, Berliner JA, and Vora DK. Minimally modified low-density lipoprotein induces monocyte adhesion on endothelial connecting segment-1 by activating beta1 integrin. J Clin Invest 103: 613-625, 1999.
25. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, and Demer LL. 8-Isoprostaglandin E2 enhances a receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277: 14221-14226, 2002.
26. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, and Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272: 13597-13607, 1997.
27. Zhang JC, Fabry A, Paucz L, Wojta J, and Binder BR. Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells. Blood 88: 3880-3886, 1996.